微信关注
Total item
Cart Subtotal
￥ 0.00 PDGFR
| Catalog No. | Inhibitor Name | PDGFR | PDGFRα | PDGFRβ | Other |
|---|---|---|---|---|---|
| A10001 | Sorafenib Tosylate | ** | ** | Raf-1,VEGFR2/Flk1,B-Raf | |
| A10468 | Imatinib Mesylate | c-Kit,v-Abl | |||
| A10880 | Sunitinib Malate | **** | FLT3,Kit,VEGFR2 | ||
| A10080 | Ponatinib | **** | Abl,VEGFR2,FGFR1 | ||
| A10103 | Axitinib | *** | **** | VEGFR1/FLT1,VEGFR2/Flk1,VEGFR3 | |
| A10259 | Imatinib | ** | c-Kit,v-Abl | ||
| A10137 | Nintedanib | ** | ** | VEGFR3,VEGFR2,LCK | |
| A10699 | Pazopanib HCl | ** | VEGFR1,VEGFR2,VEGFR3 | ||
| A11411 | Dovitinib | * | *** | FLT3,c-Kit,FGFR1 | |
| A10025 | Linifanib | ** | VEGFR1/FLT1,CSF-1R,FLT3 | ||
| A11052 | Crenolanib | **** | **** | ||
| A10558 | Masitinib | * | * | Kit,Lyn B,Abl1 | |
| A10101 | Tivozanib | *** | ** | VEGFR2,VEGFR3,EphB2 | |
| A10610 | Amuvatinib | *** | c-Kit (D816H),FLT3 (D835Y) | ||
| A10608 | Motesanib Diphosphate | ** | VEGFR1,VEGFR2,VEGFR3 | ||
| A10953 | Orantinib | *** | FGFR1,Flk1 | ||
| A11350 | CP-673451 | *** | **** | c-Kit,VEGFR2,VEGFR1 | |
| A10502 | Ki8751 | ** | VEGFR2,c-Kit,FGFR2 | ||
| A10903 | Telatinib | *** | c-Kit,VEGFR3,VEGFR2 | ||
| A11207 | PP121 | **** | Hck,VEGFR,mTOR | ||
| A11518 | Pazopanib | ** | VEGFR1,VEGFR2,VEGFR3 | ||
| A10504 | KRN 633 | * | * | VEGFR3,VEGFR2,VEGFR1 | |
| A10198 | Dovitinib Dilactic Acid | * | *** | FLT3,c-Kit,VEGFR3/FLT4 | |
| A11753 | MK-2461 | *** | c-Met (M1250T),c-Met (Y1235D),c-Met (Y1230H) | ||
| A14156 | AZD2932 | **** | Flt3,VEGFR-2,c-Kit | ||
| A15062 | DCC-2618 | *** | *** | c-Kit |
Notes:
1.Hover mouse over "" to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of "" is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
5 个项目
每页
-
Crenolanib (CP-868596)
Catalog No. A11052 PDGFR/FLT3 抑制剂Crenolanib (CP-868596)是口服生物可用的PDGFR酪氨酸激酶的选择性小分子抑制剂，在皮摩尔浓度下抑制PDGFRA和PDGFRB。 了解更多 -
Nintedanib esylate
Catalog No. A16197 RTK 抑制剂Nintedanib esylate是多种受体酪氨酸激酶（RTK）和非受体酪氨酸激酶（nRTK）的有效抑制剂。 了解更多 -
AC710 Mesylate
Catalog No. A16246 FLT3/KIT/PDGFRα/PDGFRβ 抑制剂AC710 Mesylate是一种有效的选择性PDGFR家族激酶抑制剂，对于FLT3/KIT/PDGFRα/PDGFRβ的Kd值分别为0.6 nM/1.0 nM/1.3 nM/1.0 nM。 了解更多 -
Dovitinib Dilactic acid (TKI258 Dilactic acid)
Catalog No. A10198 RTK 抑制剂Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂，可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞，IC50值分别为150 nM和90 nM。 了解更多 -
AC710
Catalog No. A15933
5 个项目
每页